10:00–10:10 am

Eric Freed, Ph.D.

Director, HIV Dynamics and Replication Program, National Cancer Institute, Frederick

Welcoming remarks

10:10–10:50 am

Felix Rey, Ph.D.

Structural Virology Unit, CNRS UMR 3569, Institut Pasteur, Paris

The hantavirus particle organization: implications for entry

10:50–11:30 am

Sarah Butcher, Ph.D.

Molecular and Integrative Biosciences Research Programme, University of Helsinki

TBEV-host protein-protein interactions on entry

11:30 am – 12:10 pm

Stefan Pöhlmann, Ph.D.

Infection Biology Unit, German Primate Center, Göttingen

SARS-CoV-2 entry into cells and its inhibition

12:10–1:10 pm

Lunch

1:10–1:50 pm

Walther Mothes, Ph.D.

Microbial Pathogenesis, Yale School of Medicine

Imaging retroviruses and SARS-CoV-2 across spatial and temporal scales

1:50–2:30 pm

Erica Ollmann Saphire, Ph.D.

La Jolla Institute for Immunology

Antibodies against SARS-CoV-2: The Global CoVIC Collaboration

2:30–3:10 pm

Daniel DiMaio, M.D., Ph.D.

Department of Genetics, Yale School of Medicine

How HPV Fishes for Cellular Protein during Entry

3:10–3:40 pm

Break

3:40–4:20 pm

Ekaterina Heldwein, Ph.D.

Massachusetts Div. of the American Cancer Society Endowed Prof. of Molecular Biology, Tufts University School of Medicine

Hello gorgeous, you’re just my type: using pseudotyping technology to elucidate HSV-1 entry mechanisms

4:20–5:00 pm

Wendy Maury, Ph.D.

Department of Microbiology and Immunology, University of Iowa

The Role of Phosphatidylserine Receptors in Enveloped Virus Infection

5:00–5:40 pm

Vinay Pathak, Ph.D.

HIV Dynamics and Replication Program, National Cancer Institute-Frederick

A Revised Model of HIV-1 Replication in Infected Cells

5:40–5:45 pm

Stephen Hughes, Ph.D.

Chief, Retroviral Replication Laboratory, National Cancer Institute, Frederick

Closing remarks